oncologic.ai
The worlds first and most advanced Oncology Process Orchestration PlatformTM
health AImedtechoncology software
StageSeries A
Raised$33.96M
Founded2026
Employees12
LocationOrlando, FL
Product
- Value proposition
- Agentic platform unifies research, clinical reasoning, operational workflows, and EHR integration to accelerate therapy decisions, reduce administrative burden, and improve precision medicine in community oncology.
- Target customers
- community oncology practices, oncology clinics
Founders
- Akshay Nanduri — Founder and CEO
- Salmaan Ahmed — Founder and VP Software
- Petr Jordan — CTO, Founding Team Member
Categories
Oncology AIClinical decision supportWorkflow automationEHR integration
Products
PAL | Practice Automation LogicORB | Oncology Research BaseARC | Advanced Reasoning Core
Key features
Automates intake, documentation, authorization support, task coordination, and follow-upContinuously organizes guidelines, biomarkers, and literature into a knowledge layerClinical reasoning to evaluate patient factors and compare therapy pathwaysEvidence-based, up-to-date therapy recommendations aligned with practice protocols
Technologies
AI-assisted workflowsGuideline alignmentBiomarker integrationEHR integration
Integrations
EHR systems
Target conditions
canceroncology indicationsbiomarker-guided therapy
Care settings
cliniccommunity oncologyvirtual
Traction metrics
Trusted by 580+ oncologists to reduce time to therapyreduces ordering time from ~20 minutes to ~396% of users find workflow intuitive
Investors
MassMutualAccompliceAction Potential Venture CapitalLife Extension VenturesSandbox/Blue Venture FundGSK plcDigitalis VenturesKdT VenturesNational Cancer Institute
News
- Clynt Taylor's Post - LinkedIn · 2026-01-26T00:00:00.000Z
- Oncora Medical - Oncology AI Solutions · 2025-03-04T00:00:00.000Z
- Onc.AI Awarded $2 Million National Cancer Institute Grant to Advance AI-based Clinical Decision Support for Metastatic NSCLC · 2024-10-24T00:00:00.000Z
- Onc.AI Announces Positive External Validation of Onclara IO, a CT Imaging AI Biomarker for First-Line Immunotherapy in PD-L1-High Metastatic Non-Small Cell Lung Cancer | Morningstar · 2026-05-28T11:00:00.000Z
- Onc.AI to Present Breakthrough Deep Learning Radiomic Biomarker Results at 2025 ASCO Annual Meeting · 2025-05-30T10:03:00.000Z
- Oncoscope-AI: REAL-SLR to Transform Oncology Pharma · 2026-01-12T20:36:44.000Z
Browse similar startups
Related startups
- OvaryIt — Tallahassee, FL
- PeleOs Technologies — Miami, FL
- Pharmax® — Fort Lauderdale, FL
- Phoilex — Doral, FL
- Reframe Nutrition — Palm City, FL
- REMMA — Miami, FL
- Oncology News Central — New York, NY
- Oncology of NorthShore — Chicago, IL
- Oncology San Antonio Cancer Care Network — San Antonio, TX
- OncoPrecision — New York, NY
- Oncoscope — New York, NY
- Oncospace — Baltimore, MD
Profile updated Jul 29, 2026. Sources: oncologic.ai
